BUPIVACAINE HCL

Generic: BUPIVACAINE HYDROCHLORIDE

Xellia Pharmaceuticals USA LLCManufacturer
PERINEURAL, INFILTRATIONRoute
BUPIVACAINE HYDROCHLORIDEActive Substance
2011-10-18Original Approval

BUPIVACAINE HCL is FDA application ANDA091503, sponsored by ONESOURCE SPECIALTY. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Class I2013-07-12
0.25% Bupivacaine HCl Injection, USP, 2.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1159-

Presence of particulate matter: visible free floating and partially embedded particulate matter in t

Class II2022-04-13
Bupivacaine Hydrochloride, USP 0.5% (5mg/mL), 25 vials x 50 mL per box, Rx only, MFG: Pfizer, NDC 0409-1163-01

cGMP deviations: Temperature abuse

Class I2013-07-12
0.75% Bupivacaine HCl Injection, USP, 7.5 mg/mL, 30 mL, Single-dose, Hospira Inc., Lake Forest, IL 60045, NDC 0409-1165-

Presence of particulate matter: visible free floating and partially embedded particulate matter in t

Class II2014-02-10
Bupivacaine HCl Inj. USP, 0.5% (5 mg/mL), 30 mL Single-dose Preservative Free Vial, Rx Only, Hospira, Inc., Lake Forest,

Presence of Particulate Matter: Confirmed customer report of visible particulate embedded in the gla

Class II2013-10-11
0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 50 mL, Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake For

Lack of assurance of sterility; equipment failure led to potential breach in asceptic process.

Class I2015-04-23
Bupivacaine Hydrochloride Inj., USP, 0.5% (5 mg/mL), Preservative-Free, 30 mL Single Use Vials, Rx only. HOSPIRA, INC.,

Presence of Particulate Matter: Presence of free-floating and embedded iron oxide particles.

Class I2021-05-03
0.5% Bupivacaine Hydrochloride Injection, USP, 150 mg/30 mL (5 mg/mL), 30 mL Single-dose Teartop Vials (NDC 0409-1162-19

Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP

Class I2016-08-04
Bupivacaine Hydrochloride Inj., USP (2.5 mg/mL) 0.25%, packaged in 30 mL Single-dose Preservative-Free vials, Rx Only, H

Presence of particulate matter: Confirmed customer report for the presence of particulate matter wit

Class II2013-09-05
0.5% Bupivacaine HCl and Epinephrine 1:200,000 Inj., 10 mL, Single-Dose Vial, NDC 0409-9045-01, Hospira, Inc., Lake Fore

Lack of Assurance of Sterility; potential for vial breakage

Class II2026-04-02
Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose Injection, USP (15 mg/2 mL) (7.5 mg/mL) ampules, Rx only, Manufactured

Lack of Assurance of Sterility

Top Reported Reactions

1
DRUG INEFFECTIVE
600 reports
2
ANAESTHETIC COMPLICATION
576 reports
3
MATERNAL EXPOSURE DURING PREGNANCY
221 reports
4
OFF LABEL USE
189 reports
5
HYPOAESTHESIA
144 reports
6
HYPOTENSION
132 reports
7
CONDITION AGGRAVATED
123 reports
8
HYPERTENSION
122 reports
9
DYSPNOEA
119 reports
10
HEADACHE
115 reports